Endothelins are potent regulators of vascular tone, which also have mitogenic, apoptotic, and immunomodulatory properties [1-3]. Three isoforms of endothelin have been identified to date, with endothelin-1 (ET-1) being the best studied. ET-1 is classically considered a potent vasoconstrictor. However, in addition to the effects of ET-1 on vascular smooth muscle cells, the peptide is increasingly recognized as a pro-inflammatory cytokine [4, 5]. ET-1 causes platelet aggregation and plays a role in the increased expression of leukocyte adhesion molecules, the synthesis of inflammatory mediators contributing to vascular dysfunction. High levels of ET-1 are found in alveolar macrophages, leukocytes [5] and fibroblasts [6]. Clinical and experimental data indicate that ET-1 is involved in the pathogenesis of sepsis [7, 8], viral and bacterial pneumonia [9, 10], Rickettsia conorii infections [11], Chagas disease [12, 13], and severe malaria [14-17]. In this minireview, we will discuss the role of endothelin in the pathogenesis of infectious processes.